Figure 4 — TP53/BRAF mutation as an aid in predicting response to immune-checkpoint inhibitor across multiple cancer types

Navigate

Research Paper|Volume 14, Issue 6|pp. 2868–2879

TP53/BRAF mutation as an aid in predicting response to immune-checkpoint inhibitor across multiple cancer types

100%

Figure 4.(A) Gene ontology (GO) and (B) Kyoto encyclopedia of gene and genomes (KEGG) pathway analysis of different expression mRNAs between TP53^MUTBRAF^WT and BRAF^MUTTP53^WT.

Figure 4 — TP53/BRAF mutation as an aid in predicting response to immune-checkpoint inhibitor across multiple cancer types | Aging